• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 2 fuera de 11 páginas
Examen

CANC 380 EXAM QUESTIONS WITH CORRECT ANSWERS LATEST UPDATE 2026

Document preview thumbnail
Vista previa 2 fuera de 11 páginas

CANC 380 EXAM QUESTIONS WITH CORRECT ANSWERS LATEST UPDATE 2026 DALY - Answers - disability adjusted life year DALY = YLD + YLL Cancer has impacted research using... - Answers 1. vaccines 2. immunotherapy 3. screening Requirements for natural selection - Answers 1. variation in population 2. heritable variation 3. variation influences survival or reproduction Natural selection cellular level - Answers - rapid - reproduce faster - random genetic mutations - favourable traits - decreased fitness Clones vs subclones - Answers clones: derived from the same parent cell - share ancestry and genetics subclones: progeny of a mutant cell from a clone HER2 - Answers - evolutionary advantage - encodes receptor for EGFR2, breast division divergent evolution - Answers single species accumulate enough phenotypic differences to diversify convergent evolution - Answers two unrelated species that do not share a common ancestry develop analogous structures due to environmental pressures parallel evolution - Answers two unrelated species share common ancestor evolve on a similar path to produce phenotypes which cells are antigen presenting? - Answers 1. dendritic cells 2. macrophages 3. B lymphocytes MHC I MHC II differences - Answers MHC-I: all nucleated cells, display cytosolic proteins MHC-II: only found on APCs, displays ingested proteins Tumour antigen products - Answers 1. mutated proteins 2. protein levels 3. glycolipids 4. oncogenic products mutated products - Answers - mutations in genes that favour uncontrolled growth - displayed by MHC pathways - abnormal protein structure causes antigenicity - RAS and proteins protein levels - Answers - tolerance to low concentration of growth-related cell proteins expressed by non-cancerous cells - abnormal expression causes antigenicity - HER2 glycolipids - Answers - over express normal glycated products to aid cell invasion - over-expression of structures cause antigenicity - gastric cancers oncogenic products - Answers - presented to MHC, immunogenic - viral products cause antigenicity - E6 E7 are displayed in cervical cells infected by the HPV innate immune response - Answers - NKC do not require activation - macrophages recognize tumour antigens and eliminate pathogens - cytokines amplify and activate - TNF stimulates coagulation adaptive immune response - Answers - present tumour antigens to helper T cells and CTLs - helper T cells produce cytokines that promote CTL development - antibodies can be developed against tumour antigens Roles of immune system in cancer development - Answers 1. immune surveillance 2. tumour destruction 3. tumour promotion 4. immune editing TNM system - Answers T: tumour; size and location N: node; spread of tumour to lymph nodes M: metastasis; spread to other parts of the body TNM Stages of cancer progression - Answers Stage 0: in situ Stage 1: localized Stage 2&3: regional spread Stage 4: distant spread Bladder cancer signalling tumour stages - Answers TIS: flat and in situ, surface Ta: papillary tumour, lumen T1: submucosal CT called the lamina propria T2a: MIBC where the tumout has extended to the muscularis propria T2b: deeper layers T3: perivesical fat T4: surrounding tissues cell differentiation - Answers less specialized cells become more specialized cell dedifferentiation - Answers - cells grow reversely from a differentiated stage to a less differentiated stage - EMT Tumour grading: differentiation and extent of proliferation - Answers G1: well-differentiated, normal G2: moderately differentiated, moderate G3: poorly differentiated, spread more G4: undifferentiated, not normal EMT in cancer progression - Answers - genetic changes that alter epithelial cells - divide rapidly and activate pathways - activated and fully parallel that normal mesenchymal processes intravasion - Answers maintains mesenchymal status of mestastasizing cell as it reaches blood vessel and enters the blood stream extravasion - Answers - exit - cells remain in mesenchymal form - MET Gleason grading - Answers 1. normal: 1-2, defined glands with layers surrounding 2. grade 3: variation in glandular size 3. grade 4: merging of glands into large cribiform glands 4. grade 5: poorly differentiated neoplasia - Answers unregulated and proliferative growth types of tissue growth - Answers 1. normal 2. hypertrophy: cell size increases 3. hyperplasia: cell number increases 4. metaplasia: replace cell 5. dysplasia: cells look different 6. anaplasia: cells form backwards 7. neoplasia: new growth how does cancer begin? - Answers 1. silencing TSG: - both alleles are inactivated - two-hit hypothesis 2. activation of an oncogene: - causes cancer - proto-oncogenes encode proteins that regulate cell growth - oncoprot4eins upregulate growth and inhibit apoptosis - oncogenes are dominant the two-hit hypothesis - Answers - both alleles of a TSG must be mutated 1. one mutation can be inherited or random; random, genetic 2. the mutation of the second allele in the cell is required; radiation, viruses epigenetic alterations that encode DNA sequences - Answers 1. random genetic mutations 2. inherited genetic mutations 3. inherited genetic alterations 4. genotoxic stress random genetic mutations - Answers - six errors every cycle - first hit to in initiate growth inherited genetic mutations - Answers - direct blood relatives - TSG or proto-oncogenes - TP53, BRCA1/BRCA2, BRAF TP53 - Answers - encodes p53 - integrity of genome - binds to damaged DNA - Li fraument syndrome Li fraument syndrome - Answers - rare hereditary cancer predisposition - osteosarcoma, breast cancer, and soft tissue sarcoma - chr 17 BRCA1/BRCA2 - Answers - response to DNA damage during DNA repair - further mutations - inheritance - melanoma - requires 2 hit - chr 17 13 BRAF - Answers - B-RAF, MAPK pathway - transcription of genes that encode proteins - V600E - melanoma, inherited heritable epigenetic alterations - Answers - methylation or acetylation of histones - gene expression - inactivation of TSG genotoxic stress - Answers - damage the genome - radiation and smoking - second hit second hit TSG - Answers - all cancers require initial transformative hit to begin - random mutations, mutations and epigenetic alterations - oncogenes one hit - TSG need two hits genomic instability - Answers high frequency of changes in the genome of a cellular lineage maintaining genome stability - Answers 1. fidelity of DNA replication in S phase 2. segregation of chromosomes in mitosis 3. precise repair of sporadic DNA 4. cell cycle checkpoints ensures genomic stability in S phase - Answers - DNA pol - repair - maturation of okazaki - telomeres ensures genomic stability in segregation - Answers - chromosome condensation - sister-chromatid cohesion - kinetochore assembly and attachment ensures genomic stability in DNA damage - Answers - DNA repair pathways - DNA damage signalling ensures genomic stability in cell cycle - Answers - G1/S: size and growth - G2/M: DNA damage and replication - S: S phase - spindle - PMC: DNA damage consequences of genomic instability - Answers 1. mutations 2. variations 3. other chromosomal abnormalities - Answers - DSBs lead to cell death - aneuploidy - fusion genes that encode proteins - gene amplification results in imbalances in factors critical for maintaining homeostasis

Vista previa del contenido

CANC 380 EXAM QUESTIONS WITH CORRECT ANSWERS LATEST UPDATE 2026

DALY - Answers - disability adjusted life year
DALY = YLD + YLL
Cancer has impacted research using... - Answers 1. vaccines
2. immunotherapy
3. screening
Requirements for natural selection - Answers 1. variation in population
2. heritable variation
3. variation influences survival or reproduction
Natural selection cellular level - Answers - rapid
- reproduce faster
- random genetic mutations
- favourable traits
- decreased fitness
Clones vs subclones - Answers clones: derived from the same parent cell
- share ancestry and genetics
subclones: progeny of a mutant cell from a clone
HER2 - Answers - evolutionary advantage
- encodes receptor for EGFR2, breast division
divergent evolution - Answers single species accumulate enough phenotypic differences to diversify
convergent evolution - Answers two unrelated species that do not share a common ancestry develop
analogous structures due to environmental pressures
parallel evolution - Answers two unrelated species share common ancestor evolve on a similar path to
produce phenotypes
which cells are antigen presenting? - Answers 1. dendritic cells
2. macrophages
3. B lymphocytes
MHC I MHC II differences - Answers MHC-I: all nucleated cells, display cytosolic proteins
MHC-II: only found on APCs, displays ingested proteins
Tumour antigen products - Answers 1. mutated proteins
2. protein levels
3. glycolipids
4. oncogenic products
mutated products - Answers - mutations in genes that favour uncontrolled growth
- displayed by MHC pathways
- abnormal protein structure causes antigenicity
- RAS and proteins
protein levels - Answers - tolerance to low concentration of growth-related cell proteins expressed by
non-cancerous cells
- abnormal expression causes antigenicity
- HER2
glycolipids - Answers - over express normal glycated products to aid cell invasion
- over-expression of structures cause antigenicity
- gastric cancers
oncogenic products - Answers - presented to MHC, immunogenic
- viral products cause antigenicity
- E6 E7 are displayed in cervical cells infected by the HPV
innate immune response - Answers - NKC do not require activation
- macrophages recognize tumour antigens and eliminate pathogens
- cytokines amplify and activate
- TNF stimulates coagulation
adaptive immune response - Answers - present tumour antigens to helper T cells and CTLs
- helper T cells produce cytokines that promote CTL development
- antibodies can be developed against tumour antigens
Roles of immune system in cancer development - Answers 1. immune surveillance
2. tumour destruction

, 3. tumour promotion
4. immune editing
TNM system - Answers T: tumour; size and location
N: node; spread of tumour to lymph nodes
M: metastasis; spread to other parts of the body
TNM Stages of cancer progression - Answers Stage 0: in situ
Stage 1: localized
Stage 2&3: regional spread
Stage 4: distant spread
Bladder cancer signalling tumour stages - Answers TIS: flat and in situ, surface
Ta: papillary tumour, lumen
T1: submucosal CT called the lamina propria
T2a: MIBC where the tumout has extended to the muscularis propria
T2b: deeper layers
T3: perivesical fat
T4: surrounding tissues
cell differentiation - Answers less specialized cells become more specialized
cell dedifferentiation - Answers - cells grow reversely from a differentiated stage to a less
differentiated stage
- EMT
Tumour grading: differentiation and extent of proliferation - Answers G1: well-differentiated, normal
G2: moderately differentiated, moderate
G3: poorly differentiated, spread more
G4: undifferentiated, not normal
EMT in cancer progression - Answers - genetic changes that alter epithelial cells
- divide rapidly and activate pathways
- activated and fully parallel that normal mesenchymal processes
intravasion - Answers maintains mesenchymal status of mestastasizing cell as it reaches blood vessel
and enters the blood stream
extravasion - Answers - exit
- cells remain in mesenchymal form
- MET
Gleason grading - Answers 1. normal: 1-2, defined glands with layers surrounding
2. grade 3: variation in glandular size
3. grade 4: merging of glands into large cribiform glands
4. grade 5: poorly differentiated
neoplasia - Answers unregulated and proliferative growth
types of tissue growth - Answers 1. normal
2. hypertrophy: cell size increases
3. hyperplasia: cell number increases
4. metaplasia: replace cell
5. dysplasia: cells look different
6. anaplasia: cells form backwards
7. neoplasia: new growth
how does cancer begin? - Answers 1. silencing TSG:
- both alleles are inactivated
- two-hit hypothesis
2. activation of an oncogene:
- causes cancer
- proto-oncogenes encode proteins that regulate cell growth
- oncoprot4eins upregulate growth and inhibit apoptosis
- oncogenes are dominant
the two-hit hypothesis - Answers - both alleles of a TSG must be mutated
1. one mutation can be inherited or random; random, genetic
2. the mutation of the second allele in the cell is required; radiation, viruses
epigenetic alterations that encode DNA sequences - Answers 1. random genetic mutations
2. inherited genetic mutations

Información del documento

Subido en
24 de febrero de 2026
Número de páginas
11
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$11.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
joshuawesonga22
3.5
(14)
Vendido
130
Seguidores
2
Artículos
15395
Última venta
3 días hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes